Assessing sample representativeness in randomized controlled trials: application to the National Institute of Drug Abuse Clinical Trials Network.

Title : Assessing sample representativeness in randomized controlled trials: application to the National Institute of Drug Abuse Clinical Trials Network

Source : PubMed
ID : 26825855
Authors : Susukida R, Crum RM, Stuart EA, Ebnesajjad C, Mojtabai R
Year : 2016
Disease Category : Drug or alcohol abuse
Focused Population : Not Specified
Priori/Posteriori : Posteriori
Single-study Generalibility? : Multiple
Score/Non-Score : Non-score
Tutorial/Method : GIST 2.0
Compared general demographic and patient characteristics : Yes
Compared disease-specific clinical characteristics : No
Compared adverse events : No
Compared outcomes/treatment effect (including survival) : No
Trial participants vs. general population (from EHR, survey, a cohort, etc) : Yes
Use propensity score : Yes
Real-world data sources : Patients drawn from the Treatment Episodes Data Set-Admissions (TEDS-A)
Target Population Data Type Levels : National